fda semaglutide compound ban Hims & Hers stock falls 25% as curtails compounded GLP-1s What is the latest update

Liu S, Zhang S-m, Ju R-j, Xiao Y, Wang X, Song X-l, Gu L-y, Cheng L, Li X-t

Intestinal barrier function in health and gastrointestinal disease

GLP-1 2

It was like, okay, theres, heres these studies going back

While BPC-157 is not a miracle, it has shown promising results in areas like: Accelerated healing of tendons, muscles, nerves, and ligaments Reduced inflammation and pain Gut lining repair, helpful in conditions like leaky gut or IBD Enhanced recovery from injury or surgery Because it supports both systemic healing and targeted gastrointestinal repair, BPC-157 appeals to a broad range of individuals from athletes recovering from injuries to those managing chronic digestive conditions

There is a big discussion about statistical significance versus clinical relevance, and it is now the case that, despite positive clinical trial outcomes, a drug company may not get marketing approval, he says